0001410384-20-000179.txt : 20201210
0001410384-20-000179.hdr.sgml : 20201210
20201210165053
ACCESSION NUMBER: 0001410384-20-000179
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201208
FILED AS OF DATE: 20201210
DATE AS OF CHANGE: 20201210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Breeden John E
CENTRAL INDEX KEY: 0001597609
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36350
FILM NUMBER: 201381181
MAIL ADDRESS:
STREET 1: 13785 RESEARCH BLVD.
STREET 2: SUITE 150
CITY: AUSTIN
STATE: TX
ZIP: 78750
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Q2 Holdings, Inc.
CENTRAL INDEX KEY: 0001410384
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 202706637
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13785 RESEARCH BOULEVARD
STREET 2: SUITE 150
CITY: Austin
STATE: TX
ZIP: 78750
BUSINESS PHONE: 512-275-0072
MAIL ADDRESS:
STREET 1: 13785 RESEARCH BOULEVARD
STREET 2: SUITE 150
CITY: Austin
STATE: TX
ZIP: 78750
FORMER COMPANY:
FORMER CONFORMED NAME: CBG Holdings, Inc.
DATE OF NAME CHANGE: 20120103
FORMER COMPANY:
FORMER CONFORMED NAME: CBG Holdings Inc
DATE OF NAME CHANGE: 20070821
4
1
wf-form4_160763704034409.xml
FORM 4
X0306
4
2020-12-08
0
0001410384
Q2 Holdings, Inc.
QTWO
0001597609
Breeden John E
13785 RESEARCH BLVD.
SUITE 150
AUSTIN
TX
78750
0
1
0
0
Chief Operating Officer
Common Stock
2020-12-08
4
M
0
1580
19.26
A
66160
D
Common Stock
2020-12-08
4
M
0
1943
35.80
A
68103
D
Common Stock
2020-12-08
4
F
0
873
114.73
D
67230
D
Stock Option (right to buy)
19.26
2020-12-08
4
M
0
1580
0
D
2017-02-16
2023-02-16
Common Stock
1580.0
0
D
Stock Option (right to buy)
35.8
2020-12-08
4
M
0
1943
0
D
2018-02-21
2024-02-21
Common Stock
1943.0
25397
D
This option grant vested as to 1/4 of the total option grant on February 16, 2017, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests.
This option grant vested as to 1/4 of the total option grant on February 21, 2018, and thereafter as to 1/48 of the total option grant monthly. The option grant becomes exercisable as it vests.
/s/ M. Scott Kerr, attorney-in-fact
2020-12-09